Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy

NCT00480389 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00480389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00480389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2007
Completion date
March 31, 2013
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic disease, renal cell carcinoma